mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |